77 F
New York
Tuesday, June 28, 2022

Novel Combo Falters in Metastatic Triple-Negative Breast Cancer

Must Read

MedPage Today) — The combination of olaparib (Lynparza) and ceralasertib, an ataxia telangiectasia and RAD3-related inhibitor, did not improve outcomes in previously treated metastatic triple-negative breast cancer versus the PARP inhibitor alone…
Read More

- Advertisement -spot_img


Please enter your comment!
Please enter your name here

- Advertisement -spot_img
Latest News

Hurricanes, Rangers each bring confidence, promising history into Game 7

RALEIGH, N.C. -- Recent history would say one thing: The Carolina Hurricanes are going to win Game 7 of...
- Advertisement -spot_img

More Articles Like This

- Advertisement -spot_img